Vineti's digital software platform for advanced cell therapy management is leading to standardization in cell and gene therapy clinical trials. The technology has been developed in partnership with Autolus Therapeutics.
In contrast to traditional therapeutics, personalized cell therapies often make the patient a key part of the treatment. Vineti, Inc. and Tessa Therapeutics are partnering to change the way personalized therapies are developed, in Asia.
